Antimicrobial Resistance (AMR) Research & Innovation: Addressing Africa’s Regional Priorities

1 September, 2016
Cape Town, South Africa

 

 

This one day gathering of 45 participants from 11 African countries aimed at advancing a collective understanding of and potential to address the most pressing antimicrobial-resistance (AMR)-related medical needs, research and development gaps, and collaboration opportunities in South Africa and other sub-Saharan countries. It specifically aimed at ensuring that the realities in countries and in practice were brought forward through a participative programme, and that recommendations be made in three key areas:

  • Public health AMR priorities in Africa: surveillance, treatments, diagnostics
  • Key elements of ensuring stewardship and sustainable access to new treatments
  • Clinical research for antibiotic treatments in and for Africa: potential for regional collaboration and clinical trial networks

 

 Meeting Report

Introduction

Welcome Remarks
Glenda Gray, President, SAMRC
Opening Remarks
Precious Matsoso, Director General, Department of Health, South Africa
WHO Global Action Plan on AMR
Mark Sprenger, Director, WHO AMR Secretariat
South African Medical Research Council, Priority Areas of Research for AMR
Glenda Gray, President, SAMRC
Global Antibiotic Research & Development Partnership, New Approaches to Delivering Innovations of Public Health Importance
Manica Balasegaram, Director, GARDP

 

Breakout Sessions

Introduction
Francis Ndowa, International Consultant, Zimbabwe
1) Public Health AMR Priorities in Africa – Surveillance, Treatments, Diagnostics
Facilitator: Marc Mendelson, University of Cape Town, South Africa

2) Key elements of ensuring stewardship and sustainable access to new treatments
Facilitator: Mirfin Mpundu, Ecumenical Pharmaceutical Network, Kenya

3) Clinical Research for Antibiotic Treatments in and for Africa: potential for regional collaboration and clinical trial networks
Facilitator: Monique Wasunna, Director DNDi Africa, Kenya

 

Panel Discussion

Introduction and Moderator:
Bernard Pécoul
, DNDi, Switzerland

Panellists:
– Chikwe Ihekweazu, Nigeria Health Watch/ EPIC Africa, Nigeria
– Ranmini Kularatne, NICD, South Africa
– Glaudina Loots, Dept. Science and Technology, South Africa

  • What are the main barriers and opportunities to building stewardship programmes and guaranteeing access?
  • How can AMR priorities translate to R&D projects for new treatments to address regional needs?
  • What are the most effective ways to build clinical research capacity and reinforce regional collaboration for clinical research?

 

Sounding Board Discussion

Moderators:
Richard Gordon, SAMRC, South Africa and Manica Balasegaram, GARDP, Switzerland

Concluding Remarks

– Glenda Gray, SAMRC, South Africa
Manica Balasegaram, GARDP, Switzerland

 

More information:

Meeting Report

Meeting Agenda

Participants

Speakers